Alcon Inc. Newsletter
-
Sight for Sore Eyes: Navigating the Ophthalmic Drugs Market 2024 | Novartis AG, Pfizer Inc, Abbvie Inc
18 Apr 2024 09:15 GMT
… Report:
◘ Abbvie Inc. (Allergan Plc)
◘ Alcon Inc.
◘ Novartis AG
◘ Pfizer Inc …
✦By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others
✦By Therapeutic …
-
Ophthalmic Drugs Market Dynamics, Growth Factors, and Industry Analysis for the Forecast Period 2023-2032
16 Apr 2024 20:08 GMT
… players such as AbbVie (Allergen), Alcon, Bausch & Lomb, F. … the demand for ophthalmic drugs.
Heightened Pharmaceutical Investments: Pharmaceutical companies are heavily … : AbbVie Inc. (Allergen plc.), Alcon Inc., Bausch & Lomb Incorporated …
-
Glaucoma Market to witness growth by 2034, estimates DelveInsight | Allergan, Santen Pharmaceutical, Kowa Ltd., Alcon
04 Apr 2024 12:30 GMT
… provides current treatment practices, emerging drugs, the market share of the … (DWTI), Kowa Ltd., Alcon, Senju Pharmaceuticals and Otsuka Pharmaceuticals Co. Ltd., TearClear, … of each drug.
Glaucoma Drugs Uptake helps in understanding the drugs with the …
-
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
02 Apr 2024 11:00 GMT
… Award for Ocular Surgery, the Alcon Research Institute (ARI) Award, the … approval is uncertain. About EyePoint Pharmaceuticals
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a … retinal diseases. The proven Durasert® drug delivery technology has been safely …
-
Alcon Names Terry Kim, MD as Chief Medical Officer and Head of Global Medical Safety
01 Apr 2024 11:19 GMT
… and clinical priorities across Alcon’s Surgical and Vision … Care and will represent Alcon in engagements with academic, … pharmaceuticals, and the expansion of the Medical Safety team.
Franck Leveiller, Alcon … of Ophthalmology (AAO).
Alcon believes that Dr. Kim …
-
Cataract Market Set to Soar by 2032: Forecasts by DelveInsight | Allergan, Merck, Pfizer, Teva Pharma, Bayer, Novartis,
25 Mar 2024 12:30 GMT
… Research Srl, EyePoint Pharmaceuticals, Alcon Research, Nacuity Pharmaceuticals, TearLab Corporation and … each drug.
Cataract Drugs Uptake helps in understanding the drugs … development activities @ Cataract Drugs and Therapies
Cataract Therapeutics …
-
Alcon launches Clareon family of intraocular lenses in India
13 Mar 2024 08:30 GMT
Mumbai: Alcon announced the launch of the Clareon family of intraocular lenses (IOLs) in India. Clareon delivers consistent visual outcomes and exceptional clarity that lasts, the clarity is born out of a glistening-free IOL material that has among the …
-
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board
14 Mar 2024 13:08 GMT
… under the Nordic Pharma brand.
Nordic Pharma is committed to … after years of experience at Alcon, Bausch & Lomb, … range of products, pharmaceutical development services and delivery … technologies.
About Nordic Pharma, Inc.
Nordic Pharma, Inc., subsidiary of …
-
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
04 Mar 2024 12:00 GMT
… the leader in sustained intraocular drug delivery, demonstrated by the compelling … roles at Ophthotech (Iveric Bio), Alcon, Replenish, Inc., and 1Co Inc … terms of grant. About EyePoint Pharmaceuticals EyePoint Pharmaceuticals (Nasdaq: EYPT) is a …
-
Palatin’s Dry Eye Drug Candidate Flops in Phase III Trial
01 Mar 2024 17:31 GMT
… added.
Palatin still touted the drug, stating that it was “clinically … the dry eye space from Alcon which posted positive top-line …